RxDoctor Payments DataLook up a doctor →

Peter Coveleski, DO

Physical Medicine & Rehabilitation · Lewes, DENPI 1770580144

Payments from drug & device makers

$9,316in general payments, 2019–2025

Across 478 payments — averaging $19.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Teva Pharmaceuticals USA, Inc.$537
  • Amgen$524
  • Novartis$494
  • Lundbeck LLC$452
  • Jazz Pharmaceuticals Inc.$376
  • plus $5K from 54 others

What the payments were for

  • Speaking & faculty fees$681%
  • Food & beverage$9,24899%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)67$1,485
Teva Pharmaceuticals USA, Inc.21$537
Amgen(2 entities)23$524
Novartis25$494
Lundbeck LLC17$452
Jazz Pharmaceuticals Inc.21$376
Lilly USA, LLC35$369
Ipsen Biopharmaceuticals, Inc16$358
Biogen19$331
Avanir Pharmaceuticals, Inc.19$285
Argenx US, Inc.9$255
Biohaven Pharmaceutical Holding Company Ltd.33$243
Pfizer14$224
Harmony Biosciences LLC7$200
Eisai Inc.9$189
Scilex Pharmaceuticals Inc.10$181
EMD Serono, Inc.8$171
AstraZeneca8$166
Tanabe Pharma America, Inc.8$164
Collegium Pharmaceutical, Inc.10$152
Otsuka America Pharmaceutical, Inc.8$144
Genentech USA, Inc.6$142
UCB, Inc.6$130
Merz Pharmaceuticals, LLC4$111
Acadia Pharmaceuticals Inc5$97
Merz North America, Inc.5$96
Acorda Therapeutics, Inc6$96
Akcea Therapeutics, Inc.1$92
Amneal Pharmaceuticals LLC4$89
Kyowa Kirin, Inc.6$88
Abbott3$67
Bristol Myers Squibb3$62
Livanova USA, Inc.3$61
Revance Therapeutics, Inc.1$59
Neurocrine Biosciences, Inc.2$58
Idorsia Pharmaceuticals US Inc3$55
Johnson & Johnson(2 entities)2$55
Boston Scientific2$51
Neurelis, Inc.3$48
Life Molecular Imaging Ltd1$48
Adamas Pharmaceuticals, Inc.3$45
Catalyst Pharmaceuticals, Inc.2$34
CSL Behring1$34
Sanofi2$32
Mallinckrodt Hospital Products Inc.1$31
Insightec,inc1$27
Axsome Therapeutics, Inc.1$27
Vanda Pharmaceuticals Inc.1$27
Mallinckrodt Enterprises LLC1$27
Averitas Pharma Inc.1$26
Grifols USA, LLC1$26
Upsher-smith Laboratories LLC2$25
Alnylam Pharmaceuticals Inc.1$23
SK Life Science, Inc.1$22
Avadel CNS Pharmaceuticals, LLC1$21
Medtronic1$21
Chiesi USA, Inc.1$19
Pacira Therapeutics, Inc.1$17
Biodelivery Sciences International, Inc.1$15
Arbor Pharmaceuticals, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,316 in reported general payments places this provider in the 90th percentile of 32 physical medicine & rehabilitation providers in Delaware.

See all physical medicine & rehabilitation providers in Delaware

Medicare billing

Part B allowed, 2024
$531,936
Medicare patients
525
Services billed
37,646

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl73$59,698
Xtampza ErOxycodone Myristate80$45,930
Oxycodone Hcl1,306$26,863
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen714$26,404
BelbucaBuprenorphine Hcl43$24,719
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen550$14,357
MovantikNaloxegol Oxalate31$13,021
Hysingla ErHydrocodone Bitartrate12$11,102
Lidocaine51$9,246
NucyntaTapentadol Hcl15$9,044
Oxymorphone Hcl ErOxymorphone Hcl15$9,014
Morphine Sulfate ErMorphine Sulfate403$8,840
Diclofenac Sodium77$5,715
Tizanidine Hcl345$4,869
Pregabalin224$4,788

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca, Nucynta$152$79,692138 claims
Upsher-smith Laboratories LLCTopiramate$25$9533 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 32 physical medicine & rehabilitation providers in Delaware.

Other physical medicine & rehabilitation in Lewes

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →